AMED CoROCO:7575 -3.85%52 EBITDA Margin % is 15.60% as of Dec. 2025, which is 15% below its 10-year median of 18.40. GuruFocus rates ROCO:7575 with a GF Score™ of 52/100 and a GF Value™ of NT$62.62 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 815 Medical Devices & Instruments companies, AMED Co ranks better than 60.98% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. AMED Co's EBITDA for the
six
months ended in Dec. 2025 was NT$65.6 Mil. AMED Co's Revenue for the
six
months ended in Dec. 2025 was NT$420.4 Mil. Therefore, AMED Co's EBITDA margin for the quarter that ended in Dec. 2025 was 15.60%.
AMED Co (ROCO:7575) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
AMED Co EBITDA Margin % Related Terms
AMED Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for AMED Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7575 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, AMED Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMED Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where AMED Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMED Co (ROCO:7575) has a EBITDA Margin % of 15.60% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AMED Co and its competitors. This is 15% below median its historical median of 18.40. Over the past decade, AMED Co's EBITDA Margin % has ranged from 13.06 to 21.02. According to the industry distribution chart, AMED Co ranks #318 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is AMED Co's EBITDA Margin % too high?
AMED Co's current EBITDA Margin % of 15.60% is 15% below median its 10-year median of 18.40. Over the past 10 years, this metric has ranged from a low of 13.06 to a high of 21.02. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. AMED Co's value of 15.60% is 108.8% above this industry median. Based on the distribution chart, AMED Co ranks #318 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AMED Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AMED Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AMED Co ranks #318 out of 815 companies for EBITDA Margin %. This puts AMED Co in the upper half of its industry. The industry median EBITDA Margin % is 7.47. AMED Co's value of 15.60% is 108.8% above this benchmark. Historically, AMED Co's own EBITDA Margin % has ranged from 13.06 to 21.02 over the past decade. While the company's 10-year median is 18.40 vs. the industry median of 7.47, AMED Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AMED Co's current EBITDA Margin % of 15.60% is 108.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on AMED Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMED Co's current EBITDA Margin % is 15.60%, which is 15% below median its own 10-year median of 18.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMED Co stock overvalued right now?
Based on GuruFocus' analysis, AMED Co (ROCO:7575) is currently considered Possible Value Trap. The stock's GF Value™ is NT$62.62, compared to a current price of NT$17.50 — trading 72.1% below its estimated fair value. The current EBITDA Margin % is 15.60%, which is 15% below median its 10-year median of 18.40 and 108.8% above the Medical Devices & Instruments industry median of 7.47. AMED Co's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For AMED Co (ROCO:7575), the current EBITDA Margin % is 15.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMED Co (ROCO:7575) Overvalued in 2026?
Based on GuruFocus' analysis, AMED Co stock appears to be undervalued.
The current stock price of NT$17.50 is trading 72.1% below its estimated GF Value™ of NT$62.62.
GuruFocus considers AMED Co to be Possible Value Trap.
Key valuation signals for ROCO:7575:
EBITDA Margin %: 15.60% (15% below median its 10-year median of 18.40)
GF Value™: NT$62.62 vs. price of NT$17.50 (72.1% below fair value)
Industry Position: 108.8% above the Medical Devices & Instruments median (#318 of 815)
No single metric tells the full story. See the ROCO:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
52GF Score
Get the complete analysis for ROCO:7575
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7575 has been successfully added to your 
